peopleInnovationCareers RarePipelineCollaborationFinanceAdvance treatment Skip to main contentSkip to navigationSkip to search
HNSA   ( ,  %) SEK
Quotes are delayed 15 minutes
Event

Investor relations contact

Investor relations

Evan Ballantyne

Chief Financial Officer

Email: IR@hansabiopharma.com